Refine by
Genomic Testing Suppliers & Manufacturers
45 companies found
based inKristiansund, NORWAY
Algea collects and processes the algae Ascophyllum nodosum to make seaweed extracts and phytocomplexes for use in agriculture. In Norway, beyond the Arctic Circle, in one of the purest and unpolluted habitats in the world, we have been harvesting ...
AlgeaFert Base Micro is one of Algea’s most special products, unique on account of its physical form: a liquid suspension of A. nodosum with green colour and creamy consistency, with a controlled and guaranteed granulometry: 80% of the ...
based inHilden, GERMANY
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins ...
For the detection of pathogens in food or animal feed samples using real-time PCR, Highly sensitive and specific detection of a broad range of pathogens, Streamlined and uniform detection protocol for all targets, Coupled to dedicated sample ...
based inValencia, SPAIN
Durviz, S.L. is a Spanish company, founded in 1979 and dedicated to the development, manufacture and distribution of productos for research and diagnostic. Our products are intended for use in the areas of Molecular Biology, Cell Biology, IVF, ...
based inLansing, MICHIGAN (USA)
Neogen Corporation (NASDAQ: NEOG) now operates out of multiple U.S. and international locations, and has a worldwide presence. Neogen develops, manufactures and markets a diverse line of products dedicated to food and animal safety. Neogen ...
based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
based inBoston, MASSACHUSETTS (USA)
Day Zero Diagnostics is located in the heart of the thriving Boston Landing area. This cutting-edge innovation space brings together the area’s leading science and technology companies and provides us with access to state-of-the-art research ...
While sample preparation technologies enable the whole genome sequencing of pathogens directly from clinical samples, once the samples have been sequenced there is a critical need for robust algorithms to interpret the sequencing data. Our ...
based inCambridge, MASSACHUSETTS (USA)
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research ...
based inHadarim, ISRAEL
Allflex is the world leader in the design, development, manufacturing and delivery of solutions for animal identification, monitoring and traceability. Our data-driven solutions are used by farmers, companies and countries to manage hundreds of ...
Lab analysis of the sample can indicate the specific disease status of the cow (BVDV status). Samples can also be used for genomic prediction, allowing the farmer to make intelligent management decisions. Many governments around the ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features. Connect with a representative in your area for more information ...
based inVancouver, BRITISH COLUMBIA (CANADA)
We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact. XPhyto is striving to have a positive impact on global health. We are creating potentially life-changing solutions through research, ...
XPhyto Therapeutics is focused on helping economies restart and businesses get up and running to bring life back to normal with a rapid, accurate and cost effective COVID ...
based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer. We’re an essential partner to patients, physicians, researchers, and biopharma ...
Foundation Medicine matches patients to precision oncology trials based on genomic alterations, tumor type, and age. Our team of expert curators and genomicists helps facilitate awareness of genomically matched clinical trial options for your ...
based inVancouver, WASHINGTON (USA)
Oasis Diagnostics® Corporation was founded to conceive, develop, and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on non-invasive specimens, particularly saliva or oral fluid. The Company’s ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes FDA-approved treatments, novel treatment ...
based inChicago, ILLINOIS (USA)
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
based inFrankfurt, GERMANY
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...
Melanoma is a serious form of skin cancer that begins in cells known as melanocytes. While it is less common than basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), melanoma is far more dangerous because of its ability to spread to other ...
based inSan Diego, CALIFORNIA (USA)
Zyagen, a biotechnology firm located in San Diego, California USA, is a leading provider of life science products and services with focus on gene expression since 2000. Zyagen develops, manufactures, and sells quality life science products, ...
Alpaca control genomic DNA is a highly pure intact high molecular size DNA. It is extracted from single tissue of single donor and treated with DNase-free RNase to remove contaminant RNA. Genomic DNA is precisely measured by Nanodrop (a ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in NSCLC for EGFR, HER2, KRAS and BRAF genes are ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
Our Guardant360® CDx test is FDA-approved for complete genomic testing across all solid cancers, providing doctors guideline-complete genomic results in 7 days from a simple ...